Evidence map›Paper›PMID 38650002›Full record

ArticleJournal of experimental & clinical cancer research : CR2024

Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.

Laura Micheli, Carmen Parisio, Elena Lucarini, Alessia Vona, Alessandra Toti, Alessandra Pacini, Tommaso Mello, Serena Boccella, Flavia Ricciardi, Sabatino Maione and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Laura Micheli *Department of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Carmen Parisio *Department of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Elena LucariniDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Alessia VonaDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Alessandra TotiDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Alessandra PaciniDepartment of Experimental and Clinical Medicine ‑ DMSC ‑ Anatomy and Histology Section, University of Florence, L.Go Brambilla 3, 50134, Florence, Italy.
Tommaso MelloDepartment of Biomedical, Experimental and Clinical Sciences, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Serena BoccellaDepartment of Experimental Medicine, Section of Pharmacology, University of Campania "L. Vanvitelli", Via Santa Maria Di Costantinopoli 16, 80138, Naples, Italy.
Flavia RicciardiDepartment of Experimental Medicine, Section of Pharmacology, University of Campania "L. Vanvitelli", Via Santa Maria Di Costantinopoli 16, 80138, Naples, Italy.
Sabatino MaioneDepartment of Experimental Medicine, Section of Pharmacology, University of Campania "L. Vanvitelli", Via Santa Maria Di Costantinopoli 16, 80138, Naples, Italy.
Grazia GrazianiDepartment of Systems Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy. graziani@uniroma2.it.
Pedro Miguel LacalIDI-IRCCS, Via Monti di Creta 104, 00167, Rome, Italy.
Paola FailliDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Carla GhelardiniDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy.
Lorenzo Di Cesare MannelliDepartment of Neuroscience, Psychology, Drug Research and Child Health ‑ NEUROFARBA ‑ Pharmacology and Toxicology Section, University of Florence, Viale G. Pieraccini 6, 50139, Florence, Italy. lorenzo.mannelli@unifi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38650002
PMCPMC11036614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.